Active Ingredient: 8Y 500IU/20mL
Dosage Form: Powder for solution for injection
- Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor VIII deficiency).
- Prevention and treatment of haemorrhage or surgical bleeding in von Willebrand disease (VWD), when desmopressin (DDAVP) treatment alone is ineffective or contra-indicated.
Packaging: Box of 1 Powder + 20 mL vial of sterilised water + 1 syringe
Manufacturer: Bio Products Laboratory Limited – UK